Skip to content
healthcare.dev

Paclitaxel

NDC 0480-3290, Paclitaxel, injection, powder, lyophilized, for suspension, from Teva Pharmaceuticals, Inc..

Product NDC
0480-3290
Status
Listed
Labeler
Teva Pharmaceuticals, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216338
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3290 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PACLITAXEL100 mg/20mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
0480-3290-01004803290011 VIAL, SINGLE-DOSE in 1 CARTON (0480-3290-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/15dd51ed-29e8-468b-b6d1-21b1f84d6f2e
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0480-3290

Use it

Look up 0480-3290 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3290 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0480-3290. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.